Largest pharmaceutical companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 pharmaceutical companies ranked by total liabilities, at SGD 177B, ahead of Pfizer (SGD 156.6B) and Johnson & Johnson (SGD 151.8B). Figures as of 18 Nov 2026, 19:59 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieSGD 177B
- Median
- SGD 2.7B
- Combined market value
- SGD 6.53T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | SGD 177B | SGD 651B | SGD 368.31 | 2.49% down | 26% up | ||
| 2 | PfizerPFE · Health Care | SGD 156.6B | SGD 206.5B | SGD 36.23 | 1.35% down | 14% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | SGD 151.8B | SGD 849.3B | SGD 352.79 | 1.86% down | 38% up | ||
| 4 | Eli LillyLLY · Health Care | SGD 110.9B | SGD 1.59T | SGD 1,784.17 | 2.28% down | 35% up | ||
| 5 | Merck & CoMRK · Health Care | SGD 108.6B | SGD 437.8B | SGD 177.60 | 3.96% down | 51% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | SGD 92.3B | SGD 157.7B | SGD 77.13 | 2.53% down | 34% up | ||
| 7 | AstraZenecaAZN · Health Care | SGD 84.3B | SGD 357.4B | SGD 230.47 | 1.97% down | 2% up | ||
| 8 | NovartisNVS · Health Care | SGD 83.1B | SGD 377.8B | SGD 200.02 | 2.55% down | 25% up | ||
| 9 | SanofiSNY · Health Care | SGD 78.8B | SGD 146.2B | SGD 60.90 | 0.66% down | 4% down | ||
| 10 | GSKGSK · Health Care | SGD 77.3B | SGD 125.9B | SGD 62.80 | 1.12% down | 6% up | ||
| 11 | Novo NordiskNVO · Health Care | SGD 66.8B | SGD 224.1B | SGD 50.84 | 3.16% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | SGD 65.3B | SGD 87.7B | SGD 27.45 | 1.64% down | 54% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | SGD 43.8B | SGD 233.8B | SGD 134.98 | 0.06% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 42.4B | SGD 63.4B | SGD 54.37 | 1.09% down | 74% up | ||
| 15 | ViatrisVTRS · Health Care | SGD 29B | SGD 30.4B | SGD 26.54 | 0.61% up | 96% up | ||
| 16 | GrifolsGRFS · Health Care | SGD 17.3B | SGD 7.4B | SGD 10.87 | 2.32% down | 1% up | ||
| 17 | ZoetisZTS · Health Care | SGD 15.7B | SGD 45B | SGD 110.82 | 2.92% up | 29% down | ||
| 18 | Royalty PharmaRPRX · Health Care | SGD 12.8B | SGD 51.4B | SGD 89.40 | 0.92% up | 78% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | SGD 12B | SGD 126.5B | SGD 1,222.55 | 1.04% down | 36% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 9.5B | SGD 20.5B | SGD 318.93 | 2.72% up | 37% up | ||
| 21 | GenmabGMAB · Health Care | SGD 9.1B | SGD 40.7B | SGD 66.02 | 1.50% down | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | SGD 9B | SGD 175.9B | SGD 693.87 | 0.70% up | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | SGD 8.8B | SGD 17.3B | SGD 34.60 | 3.77% up | 20% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | SGD 5.4B | SGD 25.5B | SGD 190.65 | 5.56% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | SGD 4.9B | SGD 59.6B | SGD 521.69 | 2.13% down | 17% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | SGD 4.7B | SGD 9.8B | SGD 28.14 | 3.31% up | 83% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | SGD 4B | SGD 6.5B | SGD 77.58 | 0.36% down | 20% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | SGD 3.9B | SGD 6B | SGD 35.93 | 3.32% up | 64% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | SGD 3.9B | SGD 19.6B | SGD 100.55 | 1.50% up | 17% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 2.7B | SGD 16.1B | SGD 19.34 | 1.39% up | 5% up | ||
| 31 | CytokineticsCYTK · Health Care | SGD 2.7B | SGD 9.2B | SGD 66.30 | 0.48% down | 20% down | ||
| 32 | Ascendis PharmaASND · Health Care | SGD 2.1B | SGD 22.9B | SGD 349.49 | 0.09% down | 28% up | ||
| 33 | InsmedINSM · Health Care | SGD 2B | SGD 34B | SGD 155.02 | 1.37% down | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | SGD 1.9B | SGD 15.3B | SGD 79.06 | 4.75% up | 11% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 1.1B | SGD 7.9B | SGD 55.97 | 0.93% up | 10% up | ||
| 36 | United TherapeuticsUTHR · Health Care | SGD 1B | SGD 31.8B | SGD 747.08 | 0.84% down | 23% up | ||
| 37 | Legend BiotechLEGN · Health Care | SGD 943.7M | SGD 4.1B | SGD 20.90 | 0.59% up | 42% down | ||
| 38 | AlkermesALKS · Health Care | SGD 861.2M | SGD 10B | SGD 59.77 | 1.96% up | 58% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 847.3M | SGD 12.1B | SGD 519.90 | 4.48% down | 24% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | SGD 775.9M | SGD 9.1B | SGD 173.11 | 1.28% down | 7% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | SGD 700.9M | SGD 7.7B | SGD 385.93 | 1.83% up | 43% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | SGD 681.2M | SGD 7.8B | SGD 119.83 | 1.03% up | 31% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | SGD 632.5M | SGD 6.3B | SGD 65.20 | 1.09% down | 44% up | ||
| 44 | Roivant SciencesROIV · Health Care | SGD 536.9M | SGD 36B | SGD 49.74 | 0.37% down | 90% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | SGD 535.6M | SGD 12.8B | SGD 84.80 | 4.83% up | 107% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | SGD 388.6M | SGD 6.3B | SGD 36.19 | 0.74% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 271.1M | SGD 10.6B | SGD 153.49 | 2.05% up | 13% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 252.8M | SGD 9.6B | SGD 122.58 | 0.08% down | 126% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | SGD 243.6M | SGD 9.6B | SGD 87.70 | 2.96% down | 8% down | ||
| 50 | ABIVAXABVX · Health Care | SGD 184.8M | SGD 9.4B | SGD 107.84 | 1.83% up | 27% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | SGD 139M | SGD 5.1B | SGD 37.11 | 2.08% down | 169% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | SGD 119.1M | SGD 10.8B | SGD 13.54 | 1.64% down | 36% down | ||
| 53 | ErascaERAS · Health Care | SGD 91.6M | SGD 6.1B | SGD 17.44 | 2.66% down | 403% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | SGD 80.7M | SGD 12.4B | SGD 130.04 | 7.47% up | 286% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | SGD 77.1M | SGD 11B | SGD 395.20 | 0.44% up | 61% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | SGD 69M | SGD 10.7B | SGD 163.31 | 1.56% up | 46% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | SGD 48.4M | SGD 6.2B | SGD 109.59 | 2.32% down | 113% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | SGD 39.1M | SGD 5.8B | SGD 53.43 | 1.47% down | 88% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | SGD 21.5M | SGD 8.4B | SGD 123.40 | 0.67% down | 241% up | ||
| 60 | Belite BioBLTE · Health Care | SGD 13M | SGD 8.2B | SGD 200.71 | 1.34% down | 31% up | ||
| 61 | VeradermicsMANE · Health Care | SGD 11.8M | SGD 6.8B | SGD 160.99 | 0.66% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2899 SGD).
Questions and answers
Which pharmaceutical companies rank first by total liabilities?
AbbVie (SGD 177B), Pfizer (SGD 156.6B) and Johnson & Johnson (SGD 151.8B) are the top three of the 61 pharmaceutical companies ranked by total liabilities as of 18 Nov 2026, 19:59 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by total liabilities have a combined market value of SGD 6.53T as of 18 Nov 2026, 19:59 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.